Senior insider sale
EVP, General Counsel, Corp Sec at VIR BIOTECHNOLOGY, INC. — senior position signals high conviction
$197.4K
21.26K shares
What this filing means
DE VERNEUIL VANINA plans to sell 21.26K shares of VIR BIOTECHNOLOGY, INC. valued at approximately $197.4K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 2/25/2026ACC: 0001959173-26-001469
Officer· EVP, General Counsel, Corp Sec
Since Feb 2026
21.26K
Shares to sell
$197.4K
Approx. market value
13.70K
Acquired (3 months)
1
Planned
2 completed
Securities Acquired — Last 3 Months2
Restricted Stock Vesting
Compensation
2/24/2026
7.51KRestricted Stock Vesting
Compensation
2/23/2026
6.19KTotal acquired13.70K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
2/24/2026 | Restricted Stock Vesting Compensation | 7.51K | — |
2/23/2026 | Restricted Stock Vesting Compensation | 6.19K | — |
| Total | 13.70K | ||
Planned & Completed Dispositions3
Completed
—Completed
Units to sell
3.12K
Market value
$29.7K
2/24/2026
—Completed
Units to sell
4.45K
Market value
$33.1K
2/23/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
13.70K
Market value
$134.5K
2/25/2026
Total
Units
21.26K
Value
$197.4K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
2/24/2026 | 3.12K | $29.7K | — | Completed |
2/23/2026 | 4.45K | $33.1K | — | Completed |
| Planned — Approximate Date | ||||
2/25/2026 | 13.70K | $134.5K | NASDAQ | Planned |
| Total | 21.26K | $197.4K | ||